SNYR · Synergy Chc Corp. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q4 '23 | Q1 '20 | Q4 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.49M | - | $8.01M | $8.13M | $30.00M | - | $10.81M | - | $6.12M | - |
| Cost of Revenue | $1.52M | - | $2.33M | $2.45M | $2.64M | - | $3.03M | - | $1.50M | - |
| Gross Profit | $3.97M | - | $5.68M | $6.24M | $6.77M | - | $7.78M | - | $4.62M | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $2.05M | - | $1.64M | $1.52M | $1.35M | - | $1.33M | - | $1.33M | - |
| Total Operating Expenses | $4.54M | - | $4.40M | $3.99M | $4.97M | - | $3.74M | - | $3.61M | - |
| D&A | $33.3K | - | $33.3K | $33.3K | $33.3K | - | $33.3K | - | $26.8K | - |
| Operating Income | ($567.1K) | - | $1.28M | $1.62M | $1.81M | - | $2.15M | - | $1.01M | - |
| Interest Expense | $2.01M | - | $1.16M | $745.5K | $414.2K | $40.0K | $446.6K | - | - | - |
| Income Tax | ($13.7K) | - | ($11.1K) | $179.4K | $127.2K | - | ($192.3K) | - | $285.5K | - |
| Net Income | ($2.57M) | - | $125.3K | $1.47M | $876.3K | - | $1.28M | - | $262.3K | - |
| EPS - Basic | ($0.23) | - | $0.01 | $0.09 | $0.08 | - | $0.17 | - | $0.00 | - |
| EPS - Diluted | ($0.23) | - | $0.01 | $0.09 | $0.08 | - | $0.17 | - | $0.00 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q4 '23 | Q1 '20 | Q4 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $292.1K | $2.62M | $1.01M | $1.46M | $177.9K | $687.9K | $632.5K | - | $314.9K | $1.22M |
| Accounts Receivable | $1.27M | $3.20M | $6.81M | $7.07M | $4.38M | $5.32M | $4.07M | - | $3.04M | $1.42M |
| Inventory | $3.38M | $3.74M | $2.15M | $2.36M | $2.35M | $1.72M | $1.91M | - | $1.71M | $1.86M |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | $6.34M | $10.01M | $20.51M | $19.51M | $15.41M | $16.06M | $11.82M | - | $5.36M | $5.05M |
| Total Assets | $6.46M | $10.16M | $20.69M | $19.73M | $15.66M | $16.34M | $12.24M | - | $5.48M | $5.19M |
| Current Liabilities | $6.85M | $8.24M | $3.83M | $7.13M | $8.07M | $17.18M | $14.02M | - | $9.80M | $10.15M |
| Long-term Debt | $25.02M | $25.06M | $25.11M | $24.98M | $10.90M | $7.46M | - | $13.10M | - | - |
| Total Liabilities | $31.87M | $33.29M | $28.94M | $32.11M | $31.30M | $32.97M | $37.34M | - | $10.05M | $10.39M |
| Stockholders' Equity | ($25.41M) | ($23.13M) | ($8.25M) | ($12.38M) | ($15.64M) | ($16.63M) | ($27.31M) | - | ($4.57M) | ($5.20M) |
| Retained Earnings | ($59.01M) | ($56.44M) | ($41.62M) | ($41.75M) | ($43.22M) | ($44.10M) | ($46.35M) | - | ($23.97M) | ($24.23M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q4 '23 | Q1 '20 | Q4 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($2.04M) | - | - | - | ($858.0K) | - | - | - | ($1.30M) | - |
| Investing Cash Flow | - | - | - | - | - | - | - | - | - | - |
| Financing Cash Flow | ($307.6K) | - | - | - | $1.00M | - | - | - | $58.0K | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q4 '23 | Q1 '20 | Q4 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 72.3% | - | 70.9% | 76.7% | 22.6% | - | 72.0% | - | 75.5% | - |
| Operating margin | -10.3% | - | 16.0% | 20.0% | 6.0% | - | 19.9% | - | 16.4% | - |
| EBITDA margin | -9.7% | - | 16.4% | 20.4% | 6.1% | - | 20.2% | - | 16.9% | - |
| Net margin | -46.8% | - | 1.6% | 18.1% | 2.9% | - | 11.9% | - | 4.3% | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 37.3% | - | 20.4% | 18.7% | 4.5% | - | 12.3% | - | 21.8% | - |
| Effective tax rate | - | - | -9.7% | 10.9% | 12.7% | - | -17.6% | - | 52.1% | - |
| Return on assets | -39.8% | - | 0.6% | 7.5% | 5.6% | - | 10.5% | - | 4.8% | - |
| Return on equity | 10.1% | - | -1.5% | -11.9% | -5.6% | - | -4.7% | - | -5.7% | - |
| Return on invested capital | - | - | 7.6% | 11.5% | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 0.93 | 1.22 | 5.35 | 2.74 | 1.91 | 0.93 | 0.84 | - | 0.55 | 0.50 |
| Quick ratio | 0.43 | 0.76 | 4.79 | 2.41 | 1.62 | 0.83 | 0.71 | - | 0.37 | 0.31 |
| Cash ratio | 0.04 | 0.32 | 0.26 | 0.20 | 0.02 | 0.04 | 0.05 | - | 0.03 | 0.12 |
| Leverage | ||||||||||
| Debt / Equity | -0.98 | -1.08 | -3.04 | -2.02 | -0.70 | -0.45 | - | - | - | - |
| Debt / Assets | 3.87 | 2.47 | 1.21 | 1.27 | 0.70 | 0.46 | - | - | - | - |
| Debt / EBITDA | - | - | 19.12 | 15.07 | 5.92 | - | - | - | - | - |
| Interest coverage | -0.3x | - | 1.1x | 2.2x | 4.4x | - | 4.8x | - | - | - |
| Equity multiplier | -0.25 | -0.44 | -2.51 | -1.59 | -1.00 | -0.98 | -0.45 | - | -1.20 | -1.00 |
| Liabilities / Assets | 4.93 | 3.28 | 1.40 | 1.63 | 2.00 | 2.02 | 3.05 | - | 1.83 | 2.00 |
| Efficiency | ||||||||||
| Asset turnover | 0.85 | - | 0.39 | 0.41 | 1.92 | - | 0.88 | - | 1.12 | - |
| Inventory turnover | 0.45 | - | 1.09 | 1.04 | 1.12 | - | 1.58 | - | 0.87 | - |
| Days sales outstanding | 84d | - | 310d | 317d | 53d | - | 138d | - | 181d | - |
| Days inventory outstanding | 811d | - | 336d | 352d | 325d | - | 230d | - | 418d | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | 244.0x | 31.7x | 29.4x | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | 2.7x | - | 3.1x | 2.6x | 0.6x | - | - | - | - | - |
| EV / EBITDA | - | - | 37.1x | 26.9x | 15.2x | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -81.7% | - | -25.9% | - | - | - | - | - | -35.4% | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | -17.2% | - |
| Revenue CAGR (5y) | - | - | - | - | 37.4% | - | 8.0% | - | 30.8% | - |
| Gross profit growth (YoY) | -41.4% | - | -27.0% | - | - | - | - | - | -33.3% | - |
| Operating income growth (YoY) | - | - | -40.4% | - | - | - | - | - | -44.9% | - |
| Net income growth (YoY) | - | - | -90.2% | - | - | - | - | - | -82.1% | - |
| EPS growth (YoY) | - | - | -94.1% | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -62.4% | -39.1% | 69.8% | - | - | - | - | - | - | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$30.38M totalNutraceuticals$29.73M · 97.9%
Beverages$631.3K · 2.1%
Consumer Goods$18.0K · 0.1%
Product / service
$33.28M totalRetail$22.25M · 66.9%
Online$8.13M · 24.4%
License Revenue$2.90M · 8.7%
Geographic
$30.38M totalUS$27.32M · 89.9%
CA$2.42M · 8.0%
MX$623.7K · 2.1%
Other$20.7K · 0.1%
Peer comparison
Same SIC group: Medicinal Chemicals & Botanical Products
Comparing Synergy CHC Corp. against the 5 most active filers in the same SIC group.